Rigel Pharmaceuticals Inc — Quarterly Cash Flow (NASDAQ:RIGL) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Total assets 163.98 M175.97 M206.74 M242.53 M513.59 M Total liabilities 160.69 M157.41 M124.8 M124.92 M122.11 M Total equity 3.29 M18.57 M81.93 M117.61 M391.48 M Total liabilities & shareholders' equities 163.98 M175.97 M206.74 M242.53 M513.59 M Total debt 59.68 M59.75 M59.81 M59.73 M52.29 M Net debt -17.64 M-17.41 M-48.62 M-77.47 M-102.72 M

뉴스

Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (NASDAQ:RIGL)

Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?

Micron and Coinbase among market cap stock movers on Wednesday

Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript

Rigel, 연간 60% 성장, 유망한 MDS 데이터 발표

Rigel Q4 2025 slides: 60% annual growth, promising MDS data

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates

X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval

Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan

Implied Volatility Surging for Rigel Pharmaceuticals Stock Options

Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline

Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates